沈阳有什么治青春痘的医院-【沈阳肤康皮肤病医院】,decjTquW,沈阳治疗腋臭去市那所医院,沈阳划痕 荨麻疹 治疗,沈阳 手术 治疗 狐臭,沈阳附二医医院皮肤科主任,沈阳哪家市立皮肤病医院好,沈阳除去腋臭多少费用

BEIJING, Dec. 7 (Xinhua) -- The Chinese government on Wednesday released a white paper on its foreign trade, highlighting the country's achievements in boosting foreign trade and contribution to the world economy.The white paper, titled China's Foreign Trade, was released by the Information Office of the State Council.The white paper introduces China's historic progress, international contribution and policies in foreign trade.
ACCRA, Dec. 1 (Xinhua) -- The Ghanaian government allayed the fears of many here on Thursday that it would provide funding for the treatment of persons living with HIV/AIDS in the country.Vice President John Dramani Mahama affirmed this when he addressed a ceremony to mark this year's World AIDS Day at Obuasi, near Kumasi, 270 km north of the capital Accra.Mahama said should the Global Fund pull out of supporting the country, the government would partner with development partners to raise the 5.8 million U. S. dollars needed yearly for the treatment of HIV/AIDS patients."Government will work together with the Ghana AIDS Commission (GAC) and donor partners to ensure that people living with HIV/ AIDS have access to antiretroviral drugs."The Presidency is with you, and whatever we will do to win the fight against HIV/AIDS shall be done," Mahama said.Ghana's HIV/AIDS infection rate, according to official figures, has dropped from 3 percent to the current 1.5 percent, albeit with pockets of higher rates of infection among some populations in the country.Mahama called for more innovativeness in mobilizing resources to avoid the danger of retrogression.Director-General of the GAC Angela El-Adas announced that the Ministry of Health had pledged 2.5 million Ghana cedis (1.66 million dollars) out of the 5.8 million dollars needed for next year.Meanwhile, in the capital, the Ghana Network of Persons Living with HIV and AIDS (NAP+ GHANA) joined persons living with HIV (PLHIV) globally on Thursday to commemorate this year's World AIDS Day."We stand united with our fellow PLHIV and the global HIV and AIDS community by fully supporting the vision of 'Getting to Zero', " Charity Owusu Danso, vice president of NAP+ Ghana, said in a message here.Established in 2005, NAP+GHANA is a network of member associations of persons living with HIV/AIDS in Ghana to represent the views, hopes and aspirations of PLHIV across the country."We are extremely worried. Everyday, we receive reports from PLHIV across the country that anti-retroviral drugs are out of stock or that hospitals or clinics won't give HIV treatment to new patients because there aren't even enough drugs for existing patients, " the statement said.

WASHINGTON, Nov. 14 (Xinhua) -- Vitamin D levels are significantly lower in patients with recurrent inflammatory spinal cord disease, according to a study published online Monday in Archives of Neurology.Vitamin D is a steroid vitamin that promotes the intestinal absorption and metabolism of calcium and phosphorus. In recent years, low levels of vitamin D have been linked to a variety of autoimmune conditions, including multiple sclerosis (MS). However, the importance of vitamin D in monophasic or recurrent non-MS spinal cord diseases including transverse myelitis and neuromyelitis optica is unknown, according to background information in the article.Transverse myelitis (TM) is a disease of the spinal cord in which there is involvement of the myelin sheath that protects nerve fibers; symptoms include back pain and weakness in the legs. Neuromyelitis optica (NMO) is a disease of the central nervous system that affects the optic nerves and spinal cord.Maureen Mealy, of Johns Hopkins University and colleagues investigated the association between low serum vitamin D levels and recurrent spinal cord disease. They analyzed data on vitamin D levels among 77 patients with monophasic (having only one phase or stage) and recurrent inflammatory diseases of the spinal cord, adjusting for season, age, sex, and race. The study found that vitamin D levels were significantly lower in patients who developed recurrent spinal cord disease."Our findings suggest that there may be an association between lower total 25-hydroxyvitamin D levels in patients with recurrent TM/NMO/ spectrum disorders as compared with their counterparts with monophasic disease," the authors report. They suggest that future studies are needed to further assess the relationship between vitamin D and recurrent spinal cord disease.
HAIFA, Israel, Oct. 5 (Xinhua) -- "It's a big day, a celebration shared by Israel, science and the entire world," Israeli researcher Daniel Shechtman, who won the 2011 Nobel Prize in chemistry, said here at a press conference at the Technion- Israel Institute of Technology.Shechtman, 70, has spent the past five decades at Technion. He is also an associate at the Ames Laboratory of the U.S. Department of Energy and has lectured at universities abroad."Thousands of scientists are currently researching the subject I developed and I'm sure that all of them view the prize as their accomplishment too," he told Xinhua, adding that, "Science (in general) wouldn't be here and be as prosperous and intricate as it is if not for the work of thousands of others around the world."The Swedish Royal Academy of Sciences on Wednesday announced Shechtman as the winner of this year's Nobel chemistry prize for his cutting-edge research on quasicrystals, a type of atom form that for decades was considered impossible by the global scientific community.The award panel explained that Shechtman's work, launched in early 1980s, has revolutionized the perception of solid matter.His work forced crstyallographers to revamp their basic conception that atoms inside crystals only have repeating and symmetrical patterns.Shechtman is the 10th Israeli scientist to win the Nobel Prize and the fourth to win the prize in chemistry.Ada Yonat, a researcher at the Weizmann Institute near Tel Aviv, received the chemistry prize in 2009.The announcement from Stockholm captured headlines in Israel, drawing praise from the country's leadership, who said Shechtman's achievement is a testament to the Jewish state's stature as a technological powerhouse.Israeli Prime Minister Benjamin Netanyahu said the winning of the Nobel Prize "expresses our people's intellect.""Every Israeli citizen is happy today and every Jew in the world is proud," a statement issued by Netanyahu's office quoted him as telling the scientist in a telephone call.Israeli President Shimon Peres, who is also a Nobel laureate, later called to congratulate Shechtman."You demonstrate that a thinking person who is hardworking and brave can make groundbreaking scientific discoveries," he said.
来源:资阳报